All In MedTech

Device Trial Radar · NCT02671968

Real-Time Continuous Glucose Monitoring (RT-CGM) in Patients With Type 1 Diabetes at High Risk for Low Glucose Values Using Multiple Daily Injections (MDI) in Germany (HYPODE-STUDY)

Last checked: Nov 19, 2026Latest source record: Mar 12, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 141 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

141

Actual

Start

Feb 2016

Primary completion

Jul 14, 2017

Study completion Oct 24, 2017

Sponsor

Lead sponsor
Science Consulting in DiabetesNot on our public-company list
Sponsor type
Industry
Collaborators
DexCom, Inc. a Delaware corporation, USA; Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm
First posted
Feb 2, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Demonstrate that usage of RT-CGM (Real time continuous glucose monitoring) reduces the frequency of low CGM-recorded glucose events in patients using MDI (Multiple daily injections) that are at risk for hypoglycemic events.

Conditions

  • Diabetes

Interventions

  • Continuous Glucose Monitoring SystemDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in the total number of low glucose events (<55 mg/dl), between baseline and outcome phase (week 22-26) in CGM group and control group (change = subtracting number of follow up events from number of baseline eventsTime frame: For each subject, the experimental phase has an expected duration of up to 7 months

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Gemeinschaftspraxis Dres. Klausmann

    Aschaffenburg, Germany

  • m&i-Fachklinik Bad Heilbrunn

    Bad Heilbrunn, Germany

  • Forschungsinstitut Diabetes-Akademie Bad Mergentheim (FIDAM)

    Bad Mergentheim, Germany

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.